These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30315639)

  • 1. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.
    Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T
    Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
    Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
    Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
    Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Zaman BA; Rasool SO; Abdo JM
    Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
    Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
    Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
    Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
    Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia.
    Li Y; Miller I; Prasad P; George NA; Parrow NL; Fleming RE
    Front Physiol; 2022; 13():893149. PubMed ID: 35634155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
    Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassay for human serum erythroferrone.
    Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
    Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
    Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
    Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
    Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
    Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2.
    Berezovsky B; Báječný M; Frýdlová J; Gurieva I; Rogalsky DW; Přikryl P; Pospíšil V; Nečas E; Vokurka M; Krijt J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Hanudel MR; Wong S; Jung G; Qiao B; Gabayan V; Zuk A; Ganz T
    Kidney Int; 2021 Jul; 100(1):79-89. PubMed ID: 33811979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroferrone contributes to recovery from anemia of inflammation.
    Kautz L; Jung G; Nemeth E; Ganz T
    Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.